Clinical Trials Browser

Phase 2 × Prostate Adenocarcinoma × fluciclovine F-18 × Clear all

NCT03762759 2024-05-17

Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes

Phase 2 Active not recruiting

Prostate Adenocarcinoma